MedTrace Logo

A Follow-up Study of Immune Dysregulation in Patients With COVID-19

NCT05669248 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-04-28

No results posted yet for this study

Summary

In order to detect the immunosuppression status of COVID-19 patients, this study collected blood samples of COVID-19 patients on the 10th, 20th and 30th days after the onset of symptoms, and detected the proinflammatory, anti-inflammatory factors，immunosuppressive marker，immune cells in the blood samples to evaluate the immunosuppression status of COVID-19 patients.

Conditions

Interventions

DIAGNOSTIC_TEST

mid covid-19 patients

Collect the patient's whole blood for testing

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-03
Primary Completion
2023-09-30
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05669248 on ClinicalTrials.gov